drugset / Trial / NCT00003876

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

NCT00003876

Phase 1 Completed Barrett Cancer Center
Treatment

Summary

RATIONALE: Internal radiation uses high-energy radiation to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining internal radiation therapy with chemotherapy implants may kill remaining tumor cells following surgery. PURPOSE: Phase I trial to study the effectiveness of internal radiation therapy plus carmustine implants in treating patients who have recurrent or refractory malignant glioma.

Timeline

Start
1999-04
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject carmustine Small molecule Other